Todd Franklin Watanabe, President and CEO at Arcutis Biotherapeutics, Inc. (ARQT), sold 5,000 shares at $24.74 ($124K) on 2022-08-05, disclosed to the SEC on 2022-08-09.
Open-market sale of $124k ARQT by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.74 | 2,500 | $62K | 50.0% |
| 2 | $24.74 | 2,500 | $62K | 50.0% |
| Total | $24.74 avg | 5,000 | $124K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |